G6PC1 and type 2 diabetes mellitus: By examining the expression of hepatic gluconeogenesis proteins, we found that MNAM intervention can reduce expression of PEPCK and G-6-Pase in the liver of obese type 2 diabetic mice, indicating that MNAM regulates hepatic gluconeogenesis in T2DM, reduces hepatic glucose output, and improves liver IR.